ImmunoPrecise Antibodies Ltd. (TSX-V: IPA) (PINK: IPATF) | Stock News Now

ImmunoPrecise Antibodies Ltd. (TSX-V: IPA) (PINK: IPATF) | Stock News Now

SNNLive spoke with Jennifer Bath, Ph.D., CEO and President of ImmunoPrecise Antibodies Ltd. (TSX-V: IPA) (PINK: IPATF) at the Small Cap Discoveries Conference 2018 in Vancouver, BC.

For more information about ImmunoPrecise Antibodies Ltd., please visit: https://immunoprecise.com/

The interview may contain forward looking statements about ImmunoPrecise Antibodies Ltd. See ImmunoPrecise Antibodies Ltd.’s periodic filings with SEDAR for more complete information.

About ImmunoPrecise Antibodies Ltd.

ImmunoPrecise is a full-service, therapeutic antibody discovery company focused on the next generation of antibody discovery, to deliver the most therapeutically-relevant antibodies, in a shorter period of time, with the highest probability of succeeding to clinical trials.

ImmunoPrecise operates from state-of-the-art laboratory facilities located at the Vancouver Island Technology Park in Victoria, British Columbia, in collaboration with its wholly-owned subsidiary operations at U-Protein Express B.V., in the Life Science Incubator, Utrecht, and ModiQuest Research, Oss, both in the Netherlands. The Company operates globally to offer antibody services from target analysis to pre-clinical studies.

The services offered to clients include antibody discovery against a broad spectrum of antigens, including challenging targets. Amongst these services, the Company offers hyridoma production, B-cell services, and a variety of phage display platforms. The Company also provides a broad range of supporting services including immunologically-based assays, recombinant protein manufacturing, humanization, optimization, stable cell line development, and advanced solutions to challenges faced by clients in antibody-related research and development. The antibodies produced by ImmunoPrecise target a wide variety of therapeutic, diagnostic and research applications.

Subscribe NOW to Stock News Now: http://bit.ly/1Q5Yfym

New videos are added almost every day to the Stock News Now channel sharing fascinating stories and companies from the MicroCap stock market.

Get more Stock News Now:
Website: http://stocknewsnow.com/
Follow Stock News Now: https://twitter.com/StockNewsNow
Like Stock News Now: https://www.facebook.com/SnnInc/
Follow Stock News Now on LinkedIn: https://www.linkedin.com/company/stoc…
Follow Stock News Now on StockTwits: http://stocktwits.com/StockNewsNow

StockNewsNow.com, The Official MicroCap News Source, is a microcap financial news portal that features news and insights from the microcap and emerging growth financial community. StockNewsNow.com is a multimedia destination hub for information about microcap and emerging growth public and private companies, market events, news, bulletins, stock quotes, expert commentary and company profiles that feature user-generated video, SNN-produced video like SNNLive CEO video interviews, Wall Street Views, SNNLive Newscasts, as well as, MicroCap Review magazine articles, guest submissions, and the latest news and headlines from MicroCap companies. Users can engage directly and share the information provided through social media.

Follow the companies YOU want to know more about; read and watch content from YOUR favorite microcap, emerging growth financial experts; register to attend financial conferences of YOUR choosing; find microcap and emerging growth financial professionals that YOU may be looking for – all here on StockNewsNow.com.
ImmunoPrecise Antibodies Ltd. (TSX-V: IPA) (PINK: IPATF) | Stock News Now